Journal
JOURNAL OF HEPATOLOGY
Volume 48, Issue 5, Pages 708-713Publisher
ELSEVIER
DOI: 10.1016/j.jhep.2008.02.010
Keywords
chronic hepatitis C infection; predictors of therapy response; genomics
Categories
Ask authors/readers for more resources
Chronic hepatitis C (HCV) infection remains a major health problem worldwide. The current standard of care is a combination of pegylated interferon-alpha and ribavirin. Considering the length of antiviral therapy, as well as its side effects and costs, accurate prediction of treatment response prior to initiation of treatment is critical. In addition to viral, demographic and environmental factors, host genetic diversity is believed to contribute to the spectrum of clinical outcomes of chronic HCV. The development of high-throughput technologies provides opportunities to define patterns of gene expression that are associated with certain disease outcomes and/or response to therapy. This article reviews genomics-based predictors of pre-treatment response to antiviral therapy. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V.. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available